Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two decades of pediatric celiac disease in a tertiary referral center: What has changed?
Krauthammer A, Guz-Mark A, Zevit N, Marderfeld L, Waisbourd-Zinman O, Silbermintz A, Mozer-Glassberg Y, Nachmias Friedler V, Rozenfeld Bar Lev M, Matar M, Assa A, Shamir R. Krauthammer A, et al. Among authors: matar m. Dig Liver Dis. 2020 Apr;52(4):457-461. doi: 10.1016/j.dld.2020.02.001. Epub 2020 Feb 26. Dig Liver Dis. 2020. PMID: 32111387
Oesophageal eosinophilia in children with coeliac disease.
Ari A, Morgenstern S, Chodick G, Matar M, Silbermintz A, Assa A, Mozer-Glassberg Y, Rinawi F, Nachmias-Friedler V, Shamir R, Zevit N. Ari A, et al. Among authors: matar m. Arch Dis Child. 2017 Sep;102(9):825-829. doi: 10.1136/archdischild-2016-311944. Epub 2017 Apr 12. Arch Dis Child. 2017. PMID: 28404554
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring.
Assa A, Matar M, Turner D, Broide E, Weiss B, Ledder O, Guz-Mark A, Rinawi F, Cohen S, Topf-Olivestone C, Shaoul R, Yerushalmi B, Shamir R. Assa A, et al. Among authors: matar m. Gastroenterology. 2019 Oct;157(4):985-996.e2. doi: 10.1053/j.gastro.2019.06.003. Epub 2019 Jun 10. Gastroenterology. 2019. PMID: 31194979 Clinical Trial.
Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn's Disease: A Post Hoc Analysis of the PAILOT Randomized Controlled Trial.
Matar M, Shamir R, Turner D, Broide E, Weiss B, Ledder O, Guz-Mark A, Rinawi F, Cohen S, Topf-Olivestone C, Shaoul R, Yerushalmi B, Ben-Horin S, Assa A. Matar M, et al. Inflamm Bowel Dis. 2020 Oct 23;26(11):1627-1635. doi: 10.1093/ibd/izz294. Inflamm Bowel Dis. 2020. PMID: 31793630 Clinical Trial.
The Effect of Adalimumab Treatment on Linear Growth in Children With Crohn Disease: A Post-hoc Analysis of the PAILOT Randomized Control Trial.
Matar M, Shamir R, Lev-Zion R, Broide E, Weiss B, Ledder O, Guz-Mark A, Rinawi F, Cohen S, Topf-Olivestone C, Shaoul R, Yerushalmi B, Assa A. Matar M, et al. J Pediatr Gastroenterol Nutr. 2020 Aug;71(2):237-242. doi: 10.1097/MPG.0000000000002728. J Pediatr Gastroenterol Nutr. 2020. PMID: 32324651 Clinical Trial.
Appraisal of the PIBD-classes Criteria: A Multicentre Validation.
Ledder O, Sonnino M, Birimberg-Schwartz L, Escher JC, Russell RK, Orlanski-Meyer E, Matar M, Assa A, Tzion RL, Shteyer E, Griffiths A, Turner D. Ledder O, et al. Among authors: matar m. J Crohns Colitis. 2020 Dec 2;14(12):1672-1679. doi: 10.1093/ecco-jcc/jjaa103. J Crohns Colitis. 2020. PMID: 32453831
260 results